250 related articles for article (PubMed ID: 1320354)
1. Some new aryl-sydnones: effects on murine tumours.
Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J
Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
Mazerska Z; Lukowicz J; Konopa J
Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
4. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
[No Abstract] [Full Text] [Related]
5. Sesquiterpene lactones XVII. Cytostatic and pharmacological activity.
Hladoń B; Chodera A
Arch Immunol Ther Exp (Warsz); 1975; 23(6):857-65. PubMed ID: 1220638
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
Flora KP; van't Riet B; Wampler GL
Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
[TBL] [Abstract][Full Text] [Related]
7. An approach to tumour biology in the light of prevention, cure and etiology.
Bose S; Chowdhury JR
Indian J Cancer; 1972 Jun; 9(2):138-41. PubMed ID: 4635904
[No Abstract] [Full Text] [Related]
8. Antitumor properties of a new folate analog, 10-deaza-aminopterin, in mice.
Sirotnak FM; DeGraw JI; Moccio DM; Dorick DM
Cancer Treat Rep; 1978 Jul; 62(7):1047-52. PubMed ID: 688246
[TBL] [Abstract][Full Text] [Related]
9. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
10. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
Iaremenko KV; Eremeeva AA; Tereshin IM
Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
[No Abstract] [Full Text] [Related]
11. [Antitumor activity of the components of a carminomycin complex].
Shorin VA; Bazhanov VS; Averbukh LA
Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
13. Isothiazolopyrimidines--new group of anticancer agents. I.
Machoń Z; Wieczorek J; Mordarski M
Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
[TBL] [Abstract][Full Text] [Related]
14. Effect of sydnone SYD-1, a mesoionic compound, on energy-linked functions of rat liver mitochondria.
Halila GC; de Oliveira MB; Echevarria A; Belém AC; Rocha ME; Carnieri EG; Martinez GR; Noleto GR; Cadena SM
Chem Biol Interact; 2007 Sep; 169(3):160-70. PubMed ID: 17644080
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
Chabner BA; Chello PL; Bertino JR
Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
[No Abstract] [Full Text] [Related]
16. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
[TBL] [Abstract][Full Text] [Related]
17. A methodological approach to the prediction of anticancer drug effect in humans.
Durkin WJ; Ghanta VK; Balch CM; Davis DW; Hiramoto RN
Cancer Res; 1979 Feb; 39(2 Pt 1):402-7. PubMed ID: 761212
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs.
Moinet-Hedin V; Tabka T; Poulain L; Godard T; Lechevrel M; Saturnino C; Lancelot JC; Le Talaër JY; Gauduchon P
Anticancer Drug Des; 2000 Apr; 15(2):109-18. PubMed ID: 10901298
[TBL] [Abstract][Full Text] [Related]
19. An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies.
Menconi E; Lepri E; Bonmassar E; Frati L; Barzi A
Int J Tissue React; 1986; 8(6):485-92. PubMed ID: 3793386
[TBL] [Abstract][Full Text] [Related]
20. Anticancer efficacy of Magainin2 and analogue peptides.
Baker MA; Maloy WL; Zasloff M; Jacob LS
Cancer Res; 1993 Jul; 53(13):3052-7. PubMed ID: 8319212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
